-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$10.7527.82% Upside
Aurinia Pharmaceuticals Inc. Frequently Asked Questions
-
What analysts cover Aurinia Pharmaceuticals Inc.?
Aurinia Pharmaceuticals Inc. has been rated by research analysts at H.C. Wainwright, Jefferies, RBC Capital, Oppenheimer in the past 90 days.